Healthcare
TG Therapeutics, Inc.
TGTX$56.09+3.30%
Price is delayed.
Add to Watchlist
About TG Therapeutics, Inc.
TG Therapeutics develops medications to treat diseases where the immune system attacks the body's own B cells. The company's main approved drug is BRIUMVI, an injection given to patients with multiple sclerosis to help reduce relapses. They are also working on pills and other injectable medicines that work in similar ways for multiple sclerosis and related conditions.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore